FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313582629> ?p ?o ?g. }

• W4313582629 endingPage "119" @default.
• W4313582629 startingPage "119" @default.
• W4313582629 abstract "Background: It is well known that the implementation of routine immunizations to prevent vaccine-preventable diseases has a significant impact on the health and well-being of infants, children, and pregnant women. We aimed to evaluate the influence of influenza, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine on the immunogenicity of SARS-CoV-2 vaccine among pregnant women, the priority population recommended for vaccination. Methods: We conducted a prospective study among pregnant women without previous SARS-CoV-2 infection in Taiwan. Maternal and umbilical cord blood samples at delivery were analyzed for the percentage of inhibition of neutralizing antibodies (NAbs) against the original strain, Delta, and Omicron variants of SARS-CoV-2 as well as the total antibody to the SARS-CoV-2 spike protein. We examined the association between different doses of SARS-CoV-2 vaccine in combination with influenza and Tdap vaccination, and two-dose SARS-CoV-2 vaccination with or without influenza and Tdap vaccines via a two-sample t-test. Results of p < 0.05 were considered to be statistically significant. Results: 98 pregnant women were enrolled in our study, with 32 receiving two doses of SARS-CoV-2 mRNA-1273 vaccine, 60 receiving three-dose of mRNA-1273, and 6 receiving one-dose of ChAdOx1 and two-dose of mRNA-1273. Twenty-one participants were immunized with SARS-CoV-2, influenza, and Tdap vaccines. Of these 21 individuals, there were no significant NAbs levels in maternal and cord blood samples against the Omicron variant, regardless of doses or type of SARS-CoV-2 vaccine. However, antibody responses against the wild-type and Delta variant were significantly lower in all maternal sera in the two-dose SARS-CoV-2 vaccine group. Among 32 women receiving two-dose mRNA-1273, significantly lower levels of NAbs in maternal sera were observed against the Delta variant and total antibody both in maternal sera and cord blood were observed in individuals receiving SARS-CoV-2 and influenza vaccine. Conclusion: This is the pilot study to demonstrate the effects of influenza and the Tdap vaccine on the immunogenicity of the SARS-CoV-2 vaccine among pregnant women. These results suggest that combination vaccination during pregnancy may result in immunogenic interactions." @default.
• W4313582629 created "2023-01-06" @default.
• W4313582629 creator A5009319194 @default.
• W4313582629 creator A5019672982 @default.
• W4313582629 creator A5028127182 @default.
• W4313582629 creator A5033522482 @default.
• W4313582629 creator A5051708774 @default.
• W4313582629 creator A5055558965 @default.
• W4313582629 creator A5059155518 @default.
• W4313582629 creator A5060562356 @default.
• W4313582629 creator A5065936082 @default.
• W4313582629 date "2023-01-03" @default.
• W4313582629 modified "2023-10-01" @default.
• W4313582629 title "Pilot Study for Immunogenicity of SARS-CoV-2 Vaccine with Seasonal Influenza and Pertussis Vaccines in Pregnant Women" @default.
• W4313582629 cites W2061675104 @default.
• W4313582629 cites W2169803204 @default.
• W4313582629 cites W3044482768 @default.
• W4313582629 cites W3121444821 @default.
• W4313582629 cites W3154888372 @default.
• W4313582629 cites W3161439325 @default.
• W4313582629 cites W3162482853 @default.
• W4313582629 cites W3171745046 @default.
• W4313582629 cites W3172786555 @default.
• W4313582629 cites W3188940990 @default.
• W4313582629 cites W3191693979 @default.
• W4313582629 cites W3215827060 @default.
• W4313582629 cites W3217195243 @default.
• W4313582629 cites W4205137086 @default.
• W4313582629 cites W4205315839 @default.
• W4313582629 cites W4205412981 @default.
• W4313582629 cites W4206320172 @default.
• W4313582629 cites W4213266776 @default.
• W4313582629 cites W4214587574 @default.
• W4313582629 cites W4220788616 @default.
• W4313582629 cites W4220830840 @default.
• W4313582629 cites W4224272725 @default.
• W4313582629 cites W4225723258 @default.
• W4313582629 cites W4225854071 @default.
• W4313582629 cites W4226164088 @default.
• W4313582629 cites W4226229183 @default.
• W4313582629 cites W4226316060 @default.
• W4313582629 cites W4242032788 @default.
• W4313582629 cites W4285814699 @default.
• W4313582629 doi "https://doi.org/10.3390/vaccines11010119" @default.
• W4313582629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36679964" @default.
• W4313582629 hasPublicationYear "2023" @default.
• W4313582629 type Work @default.
• W4313582629 citedByCount "0" @default.
• W4313582629 crossrefType "journal-article" @default.
• W4313582629 hasAuthorship W4313582629A5009319194 @default.
• W4313582629 hasAuthorship W4313582629A5019672982 @default.
• W4313582629 hasAuthorship W4313582629A5028127182 @default.
• W4313582629 hasAuthorship W4313582629A5033522482 @default.
• W4313582629 hasAuthorship W4313582629A5051708774 @default.
• W4313582629 hasAuthorship W4313582629A5055558965 @default.
• W4313582629 hasAuthorship W4313582629A5059155518 @default.
• W4313582629 hasAuthorship W4313582629A5060562356 @default.
• W4313582629 hasAuthorship W4313582629A5065936082 @default.
• W4313582629 hasBestOaLocation W43135826291 @default.
• W4313582629 hasConcept C159047783 @default.
• W4313582629 hasConcept C159654299 @default.
• W4313582629 hasConcept C203014093 @default.
• W4313582629 hasConcept C22070199 @default.
• W4313582629 hasConcept C2777351567 @default.
• W4313582629 hasConcept C2779841045 @default.
• W4313582629 hasConcept C2780572238 @default.
• W4313582629 hasConcept C2780689484 @default.
• W4313582629 hasConcept C2780868878 @default.
• W4313582629 hasConcept C2908647359 @default.
• W4313582629 hasConcept C71924100 @default.
• W4313582629 hasConcept C99454951 @default.
• W4313582629 hasConceptScore W4313582629C159047783 @default.
• W4313582629 hasConceptScore W4313582629C159654299 @default.
• W4313582629 hasConceptScore W4313582629C203014093 @default.
• W4313582629 hasConceptScore W4313582629C22070199 @default.
• W4313582629 hasConceptScore W4313582629C2777351567 @default.
• W4313582629 hasConceptScore W4313582629C2779841045 @default.
• W4313582629 hasConceptScore W4313582629C2780572238 @default.
• W4313582629 hasConceptScore W4313582629C2780689484 @default.
• W4313582629 hasConceptScore W4313582629C2780868878 @default.
• W4313582629 hasConceptScore W4313582629C2908647359 @default.
• W4313582629 hasConceptScore W4313582629C71924100 @default.
• W4313582629 hasConceptScore W4313582629C99454951 @default.
• W4313582629 hasIssue "1" @default.
• W4313582629 hasLocation W43135826291 @default.
• W4313582629 hasLocation W43135826292 @default.
• W4313582629 hasLocation W43135826293 @default.
• W4313582629 hasOpenAccess W4313582629 @default.
• W4313582629 hasPrimaryLocation W43135826291 @default.
• W4313582629 hasRelatedWork W2007936858 @default.
• W4313582629 hasRelatedWork W2052262339 @default.
• W4313582629 hasRelatedWork W2071718034 @default.
• W4313582629 hasRelatedWork W2094393858 @default.
• W4313582629 hasRelatedWork W2114347378 @default.
• W4313582629 hasRelatedWork W2143660791 @default.
• W4313582629 hasRelatedWork W2143854249 @default.
• W4313582629 hasRelatedWork W2375614090 @default.
• W4313582629 hasRelatedWork W2403273707 @default.

• next